A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.
A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.
Researchers from the University of Melbourne used three datasets containing thousands of electronic patient health records to train an existing large language model (LLM).
The AI model called DT-GPT, analysed medical data of patients with either Alzheimer’s disease or non-small cell lung cancer, as well as patients admitted to intensive care units.
The model created digital twins of these patients and forecasted how their health was likely to change over time under treatment, helping to predict the course of their disease.
Read More: University of Melbourne
